81
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

To be ionized or not to be ionized: the vital role of physicochemical properties of galbanic acid derivatives in AChE assay

ORCID Icon, &
Pages 3235-3243 | Received 05 Apr 2020, Accepted 23 Apr 2020, Published online: 15 May 2020
 

Abstract

Alzheimer’s disease is a progressive neurodegenerative disorder and patients suffer from memory loss, a decline in language skill and impairment in other cognitive functions. In the cholinergic hypothesis, dysfunction of cholinergic neurons especially in the hippocampus and cerebral cortex contributes to cognitive decline in patients. So agents that enhance acetylcholine concentration could improve cognitive function. AChEIs are among the most studied anti-Alzheimer agents. Galbanic acid as a natural compound with a sesquiterpene coumarin scaffold is a weak inhibitor of AChE. In the present contribution, we discussed the impact of carboxylic group ionization on inhibitory effects. We performed in vitro and in silico studies on galbanic acid, methyl and ethyl galbanates as AChE inhibitors. The order of inhibitory effect on AChE was obtained as ethyl galbanate ∼ methyl galbanate > galbanic acid. Our study highlights the important role of the physicochemical properties of natural lead compounds in each specific assay.

Communicated by Ramaswamy H. Sarma

Disclosure statement

The authors declare that there are no conflicts of interest.

Additional information

Funding

We are grateful to Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences (No. 950117130) for financial support of this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.